Presenter
Erin Stephenson
Bio
Erin Stephenson is a PGY4 in Neuropathology at the University of Calgary. She completed her PhD at the University of Calgary focused on neuroimmunology and multiple sclerosis.
Authors
Erin L. Stephenson1, Kristopher D. Langdon1
1 Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada
Conflict of Interest
I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose.
Clinical Summary
An 11-year-old male presents with a long-standing history of generalized muscle weakness and hyporeflexia. He was born at term following an uncomplicated pregnancy to a 28 year-old G1P0 mother in Korea; no perinatal feeding or respiratory difficulties were reported. Head lag was noted from birth. Since early childhood, he demonstrated poor strength and coordination, with current difficulties running, climbing, and inability to hop or ride a bicycle. Intellectual and social development are normal. Parents are non-consanguineous and there is no family history of neuromuscular disease. His father has Behçet’s disease and a solitary functional kidney.
On physical examination, muscle bulk and strength are diffusely reduced. Manual muscle testing (MRC grading) reveals neck flexion 2/5, hip flexion 3/5, hip extension 3/5, and 4/5 strength in the remaining muscle groups. Facial weakness is mild and symmetric. Deep tendon reflexes are absent or markedly reduced (1+ triceps). Myotonia or contractures are absent. Generalized joint hypermobility is present. Cerebellar tests and gait are normal. Growth parameters are within normal limits (height and weight 80th percentile, head circumference 61st percentile).
Laboratory studies show a normal serum creatine kinase (84 U/L). Plasma lactate, amino acids, and urine organic acids are normal. Urinalysis demonstrates persistent microscopic hematuria. Electromyography and nerve conduction studies are normal. The muscle ultrasound and skeletal muscle MRI suggest a mild to moderate non-dystrophic myopathic changes. Screening for myotonic dystrophy is negative (no DMPK or CNBP expansion). A mitochondrial panel (exome slice) is inconclusive. Muscle biopsy is pursued for further diagnostic evaluation.
Discussion points
- What are the major histological findings?
- What is the differential diagnosis?
- What ancillary testing would be most informative?
- Are there clinical implications of the diagnosis?
Reveal Diagnosis
Titin-related congenital myopathy
Trio Blueprint exome identified TTN compound-heterozygous variants, in trans.
1. TTN(NM_001267550.2):c.10032del, p.(Pro3345Leufs*29), which is likely pathogenic. This heterozygous variant, absent in gnomAD, causes an exon 43 (I band) frameshift, and is maternally inherited.
2. TTN(NM_001267550.2):c.69937_69939del, p.(Asn23313del), which is a variant of uncertain significance (VUS). This in-frame deletion of one codon in the titin A-band has one heterozygote in gnomAD, and is without in silico predictions. It has been reported once in conjunction with a second, stopgain allele (phase unknown) in a patient with myotubular myopathy (PMID 32815318, patient 16, Suppl. Table S1). This variant is paternally inherited.
I-band truncations in TTN commonly cause dilated cardiomyopathy; the concern based on the one literature report for the second, in-frame deletion allele would be a myotubular or centronuclear myopathy. TTN variants can cause congenital fiber type disproportion, multiminicores, centronuclear, or myofibrillar myopathy (PMID 29691892).
Also detected was a heterozygous, likely-pathogenic substitution in COL4A4(NM_000092.5):c.2707G>A, p.(Gly903Ser).
Pathogenic variants cause several different renal phenotypes, including Alport syndrome, thin basement membrane nephropathy / benign familial hematuria, and focal segmental glomerulosclerosis.
References
1. Rich KA, et al. Novel heterozygous truncating titin variants affecting the A-band are associated with cardiomyopathy and myopathy/muscular dystrophy. Mol Genet Genomic Med. 2020 Oct;8(10):e1460. doi: 10.1002/mgg3.1460. Epub 2020 Aug 20.
PMID: 32815318; PMCID: PMC7549586.
2. Oates EC, et al. Congenital Titinopathy: Comprehensive characterization and pathogenic insights. Ann Neurol. 2018 Jun;83(6):1105-1124. doi: 10.1002/ana.25241. PMID: 29691892; PMCID: PMC6105519.
0 Comments